DSMZ
human leukemic cell lines nalm 6 ![]() Human Leukemic Cell Lines Nalm 6, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human leukemic cell lines nalm 6/product/DSMZ Average 94 stars, based on 1 article reviews Price from $9.99 to $1999.99
human leukemic cell lines nalm 6 - by Bioz Stars,
2023-05
94/100 stars
|
Buy from Supplier |
Image Search Results
![( a , b ) Cell viability of Nalm-6 and Reh cells stable transduced with shRNA for SHOC2 or SCR control were evaluated in a 4-day MTT assay after treatment with increasing concentrations of Daunorubicin (10ηM, 25ηM, 50ηM, 100ηM and 150ηM). Results are expressed as mean absorbance [A475 nm–A650 nm] with standard deviation (S.D.) from three independent experiments. Representative viability curves after 72 h of Daunorubicin exposure show how SHOC2 absence has greatly increased daunorubicin resistance (* p < 0.05). ( c , d ) SHOC2 inhibition cleared impaired apoptosis-induced cell death in both Reh and Nalm-6 cells (*** p < 0.001) after Daunorubicin treatment for 72 h (respective IC 50 values). The bar-graphs represent mean with S.D. from three independent experiments. Statistically significant analyses are indicated by asterisks: * p < 0.05, ** p < 0.01.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_5473/pmc07495473/pmc07495473__41598_2020_72124_Fig2_HTML.jpg)
Journal: Scientific Reports
Article Title: SHOC2 scaffold protein modulates daunorubicin-induced cell death through p53 modulation in lymphoid leukemia cells
doi: 10.1038/s41598-020-72124-1
Figure Lengend Snippet: ( a , b ) Cell viability of Nalm-6 and Reh cells stable transduced with shRNA for SHOC2 or SCR control were evaluated in a 4-day MTT assay after treatment with increasing concentrations of Daunorubicin (10ηM, 25ηM, 50ηM, 100ηM and 150ηM). Results are expressed as mean absorbance [A475 nm–A650 nm] with standard deviation (S.D.) from three independent experiments. Representative viability curves after 72 h of Daunorubicin exposure show how SHOC2 absence has greatly increased daunorubicin resistance (* p < 0.05). ( c , d ) SHOC2 inhibition cleared impaired apoptosis-induced cell death in both Reh and Nalm-6 cells (*** p < 0.001) after Daunorubicin treatment for 72 h (respective IC 50 values). The bar-graphs represent mean with S.D. from three independent experiments. Statistically significant analyses are indicated by asterisks: * p < 0.05, ** p < 0.01.
Article Snippet: The commercial
Techniques: Transduction, shRNA, MTT Assay, Standard Deviation, Inhibition

Journal: Scientific Reports
Article Title: SHOC2 scaffold protein modulates daunorubicin-induced cell death through p53 modulation in lymphoid leukemia cells
doi: 10.1038/s41598-020-72124-1
Figure Lengend Snippet: ( a ) Representative immunoblot of SHOC2 knockdown (obtained from two independent shRNA) significantly impaired ERK1/2 phosphorylation. ( b ) Combined genetic inhibition of SHOC2 with Daunorubicin treatment for 24 h (40ηM) in Nalm-6 cells. Immunoblots reveal reduced p53 expression, impaired Serine 46 phosphorylation and consequently reduced p21 expression upon Daunorubicin-induced damage. Important apoptotic effectors were also affected as observed for p38 phosphorylation inhibition and reduced BAX/BCL-2 ratio (representative bar-graph in the left panel). ( c ) HUWE1 knockdown in Nalm-6 cells greatly increased SHOC2, p53 and p21 expression, confirming SHOC2-p53 interaction. As observed in immunoblot panel in ( b ) after Daunorubicin-induced damage, in SHOC2 absence decreased p53 phosphorylation and also reduced HUWE1 expression.
Article Snippet: The commercial
Techniques: Western Blot, shRNA, Inhibition, Expressing